Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 420
5
Diseases
1
Unique genes
0.500
Avg. similarity score
Bullous diffuse cutaneous mastocytosis
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Bullous diffuse cutaneous mastocytosis
Mast cell leukemia
Telangiectasia macularis eruptiva perstans
Testicular seminoma
Urticaria pigmentosa
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Bullous diffuse cutaneous mastocytosis | 4 | 4 | 1 |
| Mast cell leukemia | 4 | 4 | 1 |
| Telangiectasia macularis eruptiva perstans | 4 | 4 | 1 |
| Testicular seminoma | 4 | 4 | 1 |
| Urticaria pigmentosa | 4 | 4 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| KIT | 5 / 5 | Bullous diffuse cutaneous mastocytosis, Mast cell leukemia, Telangiectasia macularis eruptiva perstans, Testicular seminoma and 1 more |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Regulation of KIT signaling | Reactome | 1 / 14 | 858× | 1.17e-3 | 1.52e-2 ✓ sig. |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | Reactome | 1 / 15 | 801× | 1.25e-3 | 1.60e-2 ✓ sig. |
| Signaling by SCF-KIT | Reactome | 1 / 37 | 325× | 3.08e-3 | 3.13e-2 ✓ sig. |
| Acute myeloid leukemia | KEGG | 1 / 68 | 177× | 5.66e-3 | 4.75e-2 ✓ sig. |
| Central carbon metabolism in cancer | KEGG | 1 / 71 | 169× | 5.91e-3 | 4.89e-2 ✓ sig. |
| Constitutive Signaling by Aberrant PI3K in Cancer | Reactome | 1 / 75 | 160× | 6.24e-3 | 5.07e-2 |
| PIP3 activates AKT signaling | Reactome | 1 / 93 | 129× | 7.74e-3 | 5.84e-2 |
| Hematopoietic cell lineage | KEGG | 1 / 100 | 120× | 8.33e-3 | 6.12e-2 |
| Melanogenesis | KEGG | 1 / 101 | 119× | 8.41e-3 | 6.17e-2 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | Reactome | 1 / 103 | 117× | 8.58e-3 | 6.25e-2 |
| RAF/MAP kinase cascade | Reactome | 1 / 124 | 96.9× | 1.03e-2 | 7.01e-2 |
| Breast cancer | KEGG | 1 / 148 | 81.1× | 1.23e-2 | 7.75e-2 |
| Phospholipase D signaling pathway | KEGG | 1 / 149 | 80.6× | 1.24e-2 | 7.78e-2 |
| Rap1 signaling pathway | KEGG | 1 / 211 | 56.9× | 1.76e-2 | 9.59e-2 |
| Ras signaling pathway | KEGG | 1 / 237 | 50.7× | 1.97e-2 | 1.02e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| melanocyte adhesion | GO:0097326 | 1 / 1 | 18,687× | 5.35e-5 | 1.89e-3 ✓ sig. |
| positive regulation of pyloric antrum smooth muscle contraction | GO:0120072 | 1 / 1 | 18,687× | 5.35e-5 | 1.89e-3 ✓ sig. |
| positive regulation of colon smooth muscle contraction | GO:1904343 | 1 / 1 | 18,687× | 5.35e-5 | 1.89e-3 ✓ sig. |
| Kit signaling pathway | GO:0038109 | 1 / 3 | 6,229× | 1.61e-4 | 4.31e-3 ✓ sig. |
| melanocyte migration | GO:0097324 | 1 / 3 | 6,229× | 1.61e-4 | 4.31e-3 ✓ sig. |
| regulation of bile acid metabolic process | GO:1904251 | 1 / 3 | 6,229× | 1.61e-4 | 4.31e-3 ✓ sig. |
| positive regulation of small intestine smooth muscle contraction | GO:1904349 | 1 / 3 | 6,229× | 1.61e-4 | 4.31e-3 ✓ sig. |
| mast cell chemotaxis | GO:0002551 | 1 / 4 | 4,672× | 2.14e-4 | 5.28e-3 ✓ sig. |
| mast cell differentiation | GO:0060374 | 1 / 4 | 4,672× | 2.14e-4 | 5.28e-3 ✓ sig. |
| hematopoietic stem cell migration | GO:0035701 | 1 / 4 | 4,672× | 2.14e-4 | 5.28e-3 ✓ sig. |
| positive regulation of vascular associated smooth muscle cell differentiation | GO:1905065 | 1 / 4 | 4,672× | 2.14e-4 | 5.28e-3 ✓ sig. |
| positive regulation of mast cell cytokine production | GO:0032765 | 1 / 5 | 3,737× | 2.68e-4 | 6.20e-3 ✓ sig. |
| mast cell proliferation | GO:0070662 | 1 / 5 | 3,737× | 2.68e-4 | 6.20e-3 ✓ sig. |
| positive regulation of dendritic cell cytokine production | GO:0002732 | 1 / 5 | 3,737× | 2.68e-4 | 6.20e-3 ✓ sig. |
| positive regulation of mast cell proliferation | GO:0070668 | 1 / 5 | 3,737× | 2.68e-4 | 6.20e-3 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Bullous diffuse cutaneous mastocytosis | Mast cell leukemia | 0.500 | 1 | 6.49e-5 | 2.34e-4 ✓ sig. |
| Bullous diffuse cutaneous mastocytosis | Telangiectasia macularis eruptiva perstans | 0.500 | 1 | 6.49e-5 | 2.34e-4 ✓ sig. |
| Bullous diffuse cutaneous mastocytosis | Testicular seminoma | 0.500 | 1 | 6.49e-5 | 2.34e-4 ✓ sig. |
| Bullous diffuse cutaneous mastocytosis | Urticaria pigmentosa | 0.500 | 1 | 6.49e-5 | 2.34e-4 ✓ sig. |
| Mast cell leukemia | Telangiectasia macularis eruptiva perstans | 0.500 | 1 | 6.49e-5 | 2.34e-4 ✓ sig. |
| Mast cell leukemia | Testicular seminoma | 0.500 | 1 | 6.49e-5 | 2.34e-4 ✓ sig. |
| Mast cell leukemia | Urticaria pigmentosa | 0.500 | 1 | 6.49e-5 | 2.34e-4 ✓ sig. |
| Telangiectasia macularis eruptiva perstans | Testicular seminoma | 0.500 | 1 | 6.49e-5 | 2.34e-4 ✓ sig. |
| Telangiectasia macularis eruptiva perstans | Urticaria pigmentosa | 0.500 | 1 | 6.49e-5 | 2.34e-4 ✓ sig. |
| Testicular seminoma | Urticaria pigmentosa | 0.500 | 1 | 6.49e-5 | 2.34e-4 ✓ sig. |